Trinity Biotech | TRIB - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Bayer EUR 29.71B 863M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
EDAP TMS EUR 10.1M 13.22M 2026-03
J&J USD 84.97B 3.78B 2026-06
Mesa Laboratories USD 186.69M 8.22M 2025-12
OraSure Technologies USD 317.78M 4.45M 2026-06
Plus Therapeutics USD 5.46M 6.5M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Siemens EUR 68.26B 3.87B 2026-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tosoh JPY 841.22B 9.43B 2026-06
Trinity Biotech USD -71.98M 17.26M 2025-12
Veracyte USD 1.39B 44M 2026-06